The protective immune response against porcine circovirus 2 (PCV2) infection in mice was characterized using flow cytometric analysis (FCM), assays of antibody (of different IgG isotypes) and viraemia, and histopathological examination. An open reading frame 2 plasmid (pORF2) and the capsid protein (Cap) of PCV2 were used as DNA and subunit vaccines, respectively. In FCM analysis, although pORF2 and Cap alone showed comparable efficacy in eliciting lymphoproliferative responses and Cap-specific CD4+ T cells, pORF2 was superior to the Cap protein in triggering CD8+ T cells. A virus neutralization assay showed that pORF2 evoked stronger recall virus-neutralizing (VN) antibody responses than the Cap protein on PCV2 challenge. Correspondingly, VN antibody kinetics coincided with those of Cap-specific IgG2a, but not with the kinetics of IgG and IgG1. Following virus challenge, real-time PCR and histopathological analysis confirmed that only low viral DNA loads and mild microscopic lesions appeared in pORF2-immunized mice. These findings indicate that CD8+ T cells and VN antibody responses correlating mainly with Cap-specific IgG2a play crucial roles in protecting against PCV2 infection, and that the protective immunity induced by the pORF2 plasmid is superior to that induced by the PCV2 Cap protein.
AllanG. M.,
McNeillyF.,
KennedyS.,
DaftB.,
ClarkeE. G.,
EllisJ. A.,
HainesD. M.,
MeehanB. M.,
AdairB. M.1998b; Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest 10:3–10[CrossRef]
CarasovaP.,
CelerV.,
TakacovaK.,
TrundovaM.,
MolinkovaD.,
LobovaD.,
SmolaJ.2007; The levels of PCV2 specific antibodies and viremia in pigs. Res Vet Sci 83:274–278[CrossRef]
ChianiniF.,
MajoN.,
SegalesJ.,
DominguezJ.,
DomingoM.2003; Immunohistochemical characterisation of PCV2 associate lesions in lymphoid and non-lymphoid tissues of pigs with natural postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol 94:63–75[CrossRef]
EllisJ.,
HassardL.,
ClarkE.,
HardingJ.,
AllanG.,
WillsonP.,
StrokappeJ.,
MartinK.,
McNeillyF.other authors1998; Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J 39:44–51
FanH.,
XiaoS.,
TongT.,
WangS.,
XieL.,
JiangY.,
ChenH.,
FangL.2008; Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments. Mol Immunol 45:653–660[CrossRef]
FenauxM.,
HalburP. G.,
HaqshenasG.,
RoyerR.,
ThomasP.,
NawagitgulP.,
GillM.,
TothT. E.,
MengX. J.2002; Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions. J Virol 76:541–551[CrossRef]
FenauxM.,
OpriessnigT.,
HalburP. G.,
MengX. J.2003; Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs. J Virol 77:11232–11243[CrossRef]
FenauxM.,
OpriessnigT.,
HalburP. G.,
ElvingerF.,
MengX. J.2004; A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J Virol 78:6297–6303[CrossRef]
GilpinD. F.,
McCulloughK.,
MeehanB. M.,
McNeillyF.,
McNairI.,
StevensonL. S.,
FosterJ. C.,
EllisJ. A.,
KrakowkaS.other authors2003; In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system. Vet Immunol Immunopathol 94:149–161[CrossRef]
HasslungF. C.,
BergM.,
AllanG. M.,
MeehanB. M.,
McNeillyF.,
FossumC.2003; Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN- α production by porcine PBMCs. J Gen Virol 84:2937–2945[CrossRef]
HiraiT.,
NunoyaT.,
IharaT.,
SaitohT.,
ShibuyaK.,
NakamuraK.2006; Infectivity of porcine circovirus 1 and circovirus 2 in primary porcine hepatocyte and kidney cell cultures. J Vet Med Sci 68:179–182[CrossRef]
JuC.,
FanH.,
TanY.,
LiuZ.,
XiX.,
CaoS.,
WuB.,
ChenH.2005; Immunogenicity of a recombinant pseudorabies virus expressing ORF1–ORF2 fusion protein of porcine circovirus type 2. Vet Microbiol 109:179–190[CrossRef]
KamstrupS.,
BarfoedA. M.,
FrimannT. H.,
Ladekjaer-MikkelsenA. S.,
BotnerA.2004; Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 22:1358–1361[CrossRef]
KiupelM.,
StevensonG. W.,
ChoiJ.,
LatimerK. S.,
KanitzC. L.,
MittalS. K.2001; Viral replication and lesions in BALB/c mice experimentally inoculated with porcine circovirus isolated from a pig with postweaning multisystemic wasting disease. Vet Pathol 38:74–82[CrossRef]
LiuJ.,
ChenI.,
KwangJ.2005; Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol 79:8262–8274[CrossRef]
LiuJ.,
ChenI.,
DuQ.,
ChuaH.,
KwangJ.2006; The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. J Virol 80:5065–5073[CrossRef]
MaheD.,
BlanchardP.,
TruongC.,
ArnauldC.,
Le CannP.,
CarioletR.,
MadecF.,
AlbinaE.,
JestinA.2000; Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J Gen Virol 81:1815–1824
McIntoshK. A.,
HardingJ. C.,
EllisJ. A.,
AppleyardG. D.2006; Detection of Porcine circovirus type 2 viremia and seroconversion in naturally infected pigs in a farrow-to-finish barn. Can J Vet Res 70:58–61
MeehanB. M.,
McNeillyF.,
ToddD.,
KennedyS.,
JewhurstV. A.,
EllisJ. A.,
HassardL. E.,
ClarkE. G.,
HainesD. M.,
AllanG. M.1998; Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol 79:2171–2179
MosmannT. R.,
CoffmanR. L.1989b; TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173[CrossRef]
NawagitgulP.,
MorozovI.,
BolinS. R.,
HarmsP. A.,
SordenS. D.,
PaulP. S.2000; Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol 81:2281–2287
OggG. S.,
JinX.,
BonhoefferS.,
DunbarP. R.,
NowakM. A.,
MonardS.,
SegalJ. P.,
CaoY.,
Rowland-JonesS. L.other authors1998; Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103–2106[CrossRef]
QuintanaJ.,
BalaschM.,
SegalesJ.,
CalsamigliaM.,
Rodriguez-ArriojaG. M.,
Plana-DuranJ.,
DomingoM.2002; Experimental inoculation of porcine circoviruses type 1 (PCV1) and type 2 (PCV2) in rabbits and mice. Vet Res 33:229–237[CrossRef]
RuitenbergK. M.,
WalkerC.,
LoveD. N.,
WellingtonJ. E.,
WhalleyJ. M.2000; A prime–boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naive and infection-primed mice. Vaccine 18:1367–1373[CrossRef]
SchmitzJ. E.,
KurodaM. J.,
SantraS.,
SassevilleV. G.,
SimonM. A.,
LiftonM. A.,
RaczP.,
Tenner-RaczK.,
DalesandroM.other authors1999; Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857–860[CrossRef]
ShangS. B.,
LiY. F.,
GuoJ. Q.,
WangZ. T.,
ChenQ. X.,
ShenH. G.,
ZhouJ. Y.2008; Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2. Res Vet Sci 84:150–157[CrossRef]
SimmonsM.,
MurphyG. S.,
KochelT.,
RaviprakashK.,
HayesC. G.2001; Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine. Am J Trop Med Hyg 65:420–426
SinJ. I.,
BagarazziM.,
PachukC.,
WeinerD. B.1999; DNA priming–protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model. DNA Cell Biol 18:771–779[CrossRef]
SongY.,
JinM.,
ZhangS.,
XuX.,
XiaoS.,
CaoS.,
ChenH.2007; Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2. Vet Microbiol 119:97–104[CrossRef]
TangheA.,
D'SouzaS.,
RosseelsV.,
DenisO.,
OttenhoffT. H.,
DalemansW.,
WheelerC.,
HuygenK.2001; Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 69:3041–3047[CrossRef]
TruongC.,
MaheD.,
BlanchardP.,
Le DimnaM.,
MadecF.,
JestinA.,
AlbinaE.2001; Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection. Arch Virol 146:1197–1211[CrossRef]
VincentI. E.,
CarrascoC. P.,
HerrmannB.,
MeehanB. M.,
AllanG. M.,
SummerfieldA.,
McCulloughK. C.2003; Dendritic cells harbor infectious porcine circovirus type 2 in the absence of apparent cell modulation or replication of the virus. J Virol 77:13288–13300[CrossRef]
WangX.,
JiangW.,
JiangP.,
LiY.,
FengZ.,
XuJ.2006; Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice. Vaccine 24:3374–3380[CrossRef]
WangX.,
JiangP.,
LiY.,
JiangW.,
DongX.2007; Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2. Vet Microbiol 121:215–224[CrossRef]
YuS.,
OpriessnigT.,
KitikoonP.,
NilubolD.,
HalburP. G.,
ThackerE.2007; Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs. Vet Immunol Immunopathol 115:261–272[CrossRef]
ZakhartchoukA. N.,
LiuQ.,
PetricM.,
BabiukL. A.2005; Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. Vaccine 23:4385–4391[CrossRef]
ZhouJ. Y.,
ShangS. B.,
GongH.,
ChenQ. X.,
WuJ. X.,
ShenH. G.,
ChenT. F.,
GuoJ. Q.2005a; In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal. J Biotechnol 118:201–211[CrossRef]
ZhouJ. Y.,
ChenQ. X.,
YeJ. X.,
ShenH. G.,
ChenT. F.,
ShangS. B.2006; Serological investigation and genomic characterization of PCV2 isolates from different geographic regions of Zhejiang province in China. Vet Res Commun 30:205–220[CrossRef]